Imagine a world where the majestic woolly mammoth roams the Arctic tundra once again, thousands of years after its extinction. It might sound like the plot of a science fiction movie, but scientists ...

Colossal Biosciences, the biotech company behind plans to try to bring back the woolly mammoth, Tasmanian tiger and the dodo, raised another $200 million for its research.

It died out around 8,000 years ago…but in just five years the woolly mammoth could soon be walking the Earth again. Japanese scientists are behind an ambitious project to bring the long-extinct mammal ...

The woolly mammoth (Mammuthus primigenius ... It has been proposed the species could be recreated through cloning, but this method is as yet infeasible because of the degraded state of the ...

A team of researchers claim that, with help from gene editing methods like CRISPR, they could conceivably be capable of cloning a Woolly Mammoth back from extinction in two years or less.

An ancient skeleton of a woolly mammoth has sold for €548,000 (£483,000; $640,000) at auction in the French city of Lyon. The skeleton, which exceeded its estimated value, is thought to be the ...

Each new woolly mammoth carcass to emerge from the ... the scientists conjectured that the same techniques might open the door to cloning mammoths and other extinct species preserved in permafrost.

(Bloomberg) -- A biotechnology startup working to bring back animals from extinction has raised $200 million at a valuation of $10.2 billion, more than six times its valuation just two years ago.

Colossal Biosciences, the biotech company behind plans to revive the woolly mammoth, dodo and Tasmanian tiger ... Scientists are pioneering and refining three techniques in their attempts to revive ...

Colossal Biosciences, the company that’s famously on a mission to bring back the woolly mammoth and two other extinct species, has raised a $200 million Series C at a $10.2 billion valuation ...